Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

17 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Emerging targets for combination therapy in melanomas.
Saito Rde F, Tortelli TC Jr, Jacomassi MD, Otake AH, Chammas R. Saito Rde F, et al. Among authors: otake ah. FEBS Lett. 2015 Nov 14;589(22):3438-48. doi: 10.1016/j.febslet.2015.09.022. Epub 2015 Oct 6. FEBS Lett. 2015. PMID: 26450371 Free article. Review.
Accumulation of prohibitin is a common cellular response to different stressing stimuli and protects melanoma cells from ER stress and chemotherapy-induced cell death.
Tortelli TC Junior, de Godoy LMF, de Souza GA, Bonatto D, Otake AH, de Freitas Saito R, Rosa JC, Greene LJ, Chammas R. Tortelli TC Junior, et al. Among authors: otake ah. Oncotarget. 2017 Jun 27;8(26):43114-43129. doi: 10.18632/oncotarget.17810. Oncotarget. 2017. PMID: 28562344 Free PMC article.
Cell internalization of 7-ketocholesterol-containing nanoemulsion through LDL receptor reduces melanoma growth in vitro and in vivo: a preliminary report.
Favero GM, Paz JL, Otake AH, Maria DA, Caldini EG, de Medeiros RSS, Deus DF, Chammas R, Maranhão RC, Bydlowski SP. Favero GM, et al. Among authors: otake ah. Oncotarget. 2018 Feb 4;9(18):14160-14174. doi: 10.18632/oncotarget.24389. eCollection 2018 Mar 6. Oncotarget. 2018. PMID: 29581835 Free PMC article.
Mesenchymal stem cells do not prevent antibody responses against human α-L-iduronidase when used to treat mucopolysaccharidosis type I.
Martin PK, Stilhano RS, Samoto VY, Takiya CM, Peres GB, da Silva Michelacci YM, da Silva FH, Pereira VG, D'Almeida V, Marques FL, Otake AH, Chammas R, Han SW. Martin PK, et al. Among authors: otake ah. PLoS One. 2014 Mar 18;9(3):e92420. doi: 10.1371/journal.pone.0092420. eCollection 2014. PLoS One. 2014. PMID: 24642723 Free PMC article.
17 results